Copycat Ozempic, Mounjaro proliferate even in postshortage era

Copycat versions of fashionable drugs similar Ozempic and Mounjaro person continued to proliferate successful a postshortage era, with immoderate experts saying “regulatory neglect” is allowing for perchance dangerous, unapproved drugs to scope consumers.  When the Food and Drug Administration (FDA) adds a cause to its authoritative shortage list, compounding pharmacies tin merchantability their ain versions…